These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality? Marsh DA, Hoar ME. Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245 [Abstract] [Full Text] [Related]
14. FDA inspections of large volume and small volume parenteral manufacturers. Shepherd RE. Bull Parenter Drug Assoc; 1976; 30(5):209-13. PubMed ID: 974306 [No Abstract] [Full Text] [Related]
17. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P, Chan CC, Carrano J, Gosnell M, Gu ZQ, Maule A, Sigvardson K, Zhang YF. Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
18. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century. Kweder SL. Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917 [No Abstract] [Full Text] [Related]
19. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2006 Jun 02; 71(106):32105-6. PubMed ID: 16795933 [Abstract] [Full Text] [Related]